SCHEDULE OF OUTSTANDING AND EXERCISABLE WARRANTS (Details) - USD ($) |
6 Months Ended | 12 Months Ended |
|---|---|---|
Jun. 30, 2026 |
Dec. 31, 2025 |
|
| Warrants | ||
| Warrants outstanding, balance | 177,536 | |
| Weighted average exercise price outstanding, balance | $ 22.50 | |
| Contractual life in years, warrants outstanding | 1 year 3 months 7 days | 1 year 9 months 3 days |
| Intrinsic value warrants outstanding, balance | ||
| Warrants granted | ||
| Weighted average exercise price, warrants granted | ||
| Warrants forfeited, expired, cancelled | ||
| Weighted average exercise price, warrant forfeited, expired, cancelled | ||
| Warrants exercised | ||
| Weighted average exercise price, warrant exercised | ||
| Warrants outstanding, balance | 177,536 | 177,536 |
| Weighted average exercise price outstanding, balance | $ 22.50 | $ 22.50 |
| Intrinsic value warrants outstanding, balance | ||
| Warrants exercisable, balance | 177,536 | |
| Weighted average exercise price exercisable, balance | $ 22.50 | |
| Contractual life in years, warrants exercisabl | 1 year 3 months 7 days | |
| Intrinsic value warrants exercisable, balance |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity exercisable weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments exercisable. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by sharebasedpayment award non option equity instruments exercises in period weighted average exercise price No definition available.
|
| X | ||||||||||
- Definition Weighted Average Exercise Price, Warrants Forfeited. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments grants in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock non-option equity plan. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average remaining contractual term. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non options equity instrument exercisable intrinsic value. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non options equity instrument outstanding intrinsic value. No definition available.
|
| X | ||||||||||
- Definition Contractual Life Warrants, Warrants Exercisable Ending. No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were either cancelled or expired. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|